Cell4Cure AB
PrivateCompany Overview
Cell4Cure AB is a biotechnology company that develops autologous cell-based therapies for immune tolerance induction to treat autoimmune diseases and anti-drug antibodies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
cell therapydendritic cellsimmune tolerancetolerogenic dendritic cellstolDCautologous cell therapyex vivo engineeringbiotechimmunotherapyautoimmune disease treatmenttransplant rejectionhemophilia Aclinical-stage biotechnext-gen immunotherapyprecision medicine
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cell4Cure AB Comparables
Compare Cell4Cure AB with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Rezq Bio | 86% | |
| TolerogenixX GmbH | 81% | |
| Anokion | 77% | |
Cell4Cure AB Funding Rounds
Historical fundraising activity
Cell4Cure AB Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cell4Cure AB's valuation, stock price, and market status.
See something wrong or outdated?